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The serotonin transporter (SERT) is a key molecule involved in the homeostasis of extracellular levels of serotonin and is
regulated developmentally. Genetic deletion of SERT in rodents increases extracellular levels of serotonin and affects cellular
processes involved in neocortical circuit assembly such as barrel cortex wiring and cortical interneuron migration. Importantly,
pharmacological blockade of SERT during brain development leads to phenotypes relevant to psychiatry in rodents and to an
increased risk for autism spectrum disordersin humans. Furthermore, developmental adversity interactswithgenetically-driven
variations of serotonin function in humans and nonhuman primates to increase the risk for a variety of stress-related
phenotypes. In this study, we investigate whether an excess of serotonin affects the migration of neocortical pyramidal neurons
duringdevelopment.Using inutero electroporationcombinedwithtime-lapseimagingtospeciﬁcally monitorpyramidalneurons
during late mouse embryogenesis, we show that an excess of serotonin reversibly affects the radial migration of pyramidal
neurons. We further identify that the serotonin receptor 5-HT6 is expressed in pyramidal neuron progenitors and that 5-HT6
receptor activation replicates the effects of serotonin stimulation. Finally, we show that the positioning of superﬁcial layer
pyramidal neurons is altered in vivo in SERT knockout mice. Taken together, these results indicate that a developmental excess
ofserotonindecreasesthemigrationspeedofcorticalpyramidalneurons,affectingafundamentalstepintheassemblyofneural
circuits. These ﬁndings support the hypothesis that developmental dysregulation of serotonin homeostasis has detrimental
effects on neocortical circuit formation and contributes to increased vulnerability to psychiatric disorders.
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Introduction
Vulnerability to psychiatric disorders is likely to have an early
developmental origin. Understanding the molecular mechan-
isms controlling the assembly of cortical circuits and how
abnormal neocortical circuit formation leads to psychiatric
disorders is a fundamental question.
1 Neuronal migration is a
critical early step in the construction of cortical circuits,
ultimately determining the cell-subtype-speciﬁc positioning of
differentiating neurons in the distinct cortical layers.
2 Abnor-
mal positioning of the distinct subtypes of neurons is likely
to impair the subsequent establishment of interneuronal
connectivity and the function of cortical circuits.
3 Inhibitory
interneurons and excitatory projection neurons are born in
different regions of the telencephalon, and their migration
is largely determined by the combinatorial expression of
different sets of transcription factors.
2 Projection neurons are
generated in the ventricular zone (VZ) of the developing
pallium and migrate radially to reach their ﬁnal laminar
position.
2 In contrast, inhibitory interneurons mainly originate
from the ganglionic eminences of the subpallium and migrate
ﬁrsttangentiallytowardthepalliumbeforeradiallyinvadingthe
cortical plate.
2 Several genetic networks controlling neuronal
diversity and migration are associated with developmental
and adult psychiatric disorders.
3 Among these signaling
networks, the serotonergic system has been shown
to regulate cellular events critical for the proper assembly of
neural circuits,
4 such as thalamocortical wiring
5 and neuronal
migration.
6 A regulatory role for serotonin in cell migration is
observed in non-neuronal cells such as eosinophils in the
immune system,
7 pulmonary artery smooth muscle cells,
8
aortic smooth muscle cells,
9 aortic endothelial cells
10 and
mesenchymal cells.
11 In the developing nervous system,
both excess of serotonin resulting from the deletion of the
serotonin transporter (SERT)
6 and depletion of serotonin
12,13
impair interneuron migration. Understanding the role of
serotonin during cortical circuit formation is relevant for
psychiatric disorders for several reasons. First, at a behav-
ioral level, SERT blockade during the prenatal or early
postnatal period gives rise to stress-related phenotypes in
adulthood.
14–16Second, inhumans andnon-humanprimates,
a hypofunctional polymorphism (5-HTTLPR, short allele)
in the promoter region of the SERT gene interacts
with developmental adversity to increase the risk for affective
dysregulation.
17–23 Furthermore, the 5-HTTLPR s-allele is
associated with speciﬁc clinical subdomains of autistic
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24 and with increases in cerebral cortical gray matter
volume in children with autism.
25 Finally, recent data indicate
that prenatal exposure to selective serotonin reuptake
inhibitors increases the risk of developing autism spectrum
disorders.
26
A developmental excess of serotonin could thus critically
impair the formation of neuronal circuits and increase
vulnerability to a broad range of psychiatric disorders. In this
study,we soughtto determine whether anexcessof serotonin
could affect the migration of excitatory pyramidal neurons, an
early developmental process necessary for the subsequent
formation of neocortical circuits.
2 By combining in utero
electroporation with time-lapse imaging, we ﬁnd that an
excess of serotonin decreases the migration speed of
pyramidal neurons. We report that the serotonin receptor
subtype 6 (5-HT6) is expressed throughout the developing
cortex during the late embryonic period and that activation of
the 5-HT6 receptor decreases pyramidal neuron migration
speed. Finally, we ﬁnd that the positioning of superﬁcial layer
cortical projection neurons is altered in SERT knockout mice,
indicating that an excess of serotonin can affect pyramidal
neuron migration in vivo.
Materials and methods
Animals. All animal experiments were conducted in accor-
dance with international and Swiss laws. The day of the
vaginal plug detection was counted as embryonic day 0.5
(E0.5). We used wild-type C57Bl/6 mice, transgenic mice
expressing GFP under the control of the GAD65 promoter
(GAD65-GFP mice)
6 or homozygote SERT ko mice
crossed to GAD65-GFP mice, all maintained on a C57Bl/6
background.
6
In utero electroporation, cortical slice preparation and
time-lapse imaging. To label pyramidal neurons, embryos
from timed pregnant E14.5 or E16.5, dams were electro-
porated in the VZ of the dorsal pallium with a plasmid
expressing a red ﬂuorochrome (tomato, TOM) under the
regulation of the ubiquitin promoter. After in utero
electroporation, dams were killed by intraperitoneal pento-
barbital injection (50mgkg
 1), and embryos collected at
E17.5 or E19.0. P0.5 pups were killed by rapid decapitation.
Cortical slices (200mm thick) were cut on a vibratome, placed
on porous nitrocellulose ﬁlters (Millicell-CM, Millipore, Zug,
CH) and kept in neurobasal medium (Invitrogen, Zug, CH)
supplemented with 2% B27 (Invitrogen) as previously
described.
6
Cell culture experiments. To test the speciﬁcity of the
5-HT6 receptor antibody, transfections were performed on
293 T cells using a pEGFP-5-HT6-expressing plasmid
(kind gift of Dr Kirk Mykytyn)
27 diluted in OptiMEM
(Invitrogen) together with Lipofectamine 2000 transfection
reagent (Invitrogen). To stain pyramidal neurons and
GAD65-GFPþ interneurons in vitro, E17.5 cortical slices
from E14.5 electroporated embryos were prepared, cortices
were dissected and trypsinized in Hanks’ medium for 10min
at 371C, TOMþ and GAD65-GFPþ cells were isolated
using ﬂuorescence-activated cell sorting (FACS),
6 platted
on polyornithine-coated petri dishes (Invitrogen) and
immunostained with a 5-HT6 antibody at day in vitro 1.
Tissue processing and immunohistochemistry. Animals
were deeply anesthetized by pentobarbital intraperitoneal
injection (50mgkg
 1), and killed by intracardial perfusion of
0.9% saline followed by cold 4% paraformaldehyde (PFA)
(pH 7.4). Brains were post-ﬁxed 48h in 4% PFA at 41C
and coronal sections were cut on a vibratome and stored
at 41C in 0.1M phosphate-buffered saline. Free-ﬂoating
immunohistochemistry on sections was performed as
previously described.
6 Primary antibodies were used at the
following concentrations: rabbit anti-5-HT6 (1:100; Abcam,
Cambridge, UK), rabbit anti-serotonin (1:5000; Sigma, Buchs,
CH) and mouse anti-acetylated tubulin (1:500; Sigma).
Image acquisition and analysis. Cortical slices were
imaged in a thermoregulated chamber and time-lapse
movies were acquired using a ﬂuorescent microscope
(Eclipse TE2000, Nikon, Amstelveen, NE) as previously
described.
6 Images were acquired using the Open-lab
software (version 5.0, Waltham, MA, USA) every 10min for
over 16h. Time-lapse stacks were generated and analyzed
using Metamorph software (version 7.4, Oxford, UK). TOMþ
cells located in the intermediate zone and migrating radially
during time-lapse sequences were selected for single-cell
tracking at E17.5 and at P0.5. A total of 60–110 cells in at
least three separate experiments were quantiﬁed for each
experimental condition. For treatment conditions, 5-HT 400mM
(Sigma, diluted in H2O) or EMD 386088 300mM (Tocris,
Bristol, UK, diluted in H2O) was applied in the bath medium
during 90min after a control time-lapse sequence of at
least 260min. After washing out the drug, TOMþ cells were
monitored for at least 590min. To obtain confocal images of
ﬂuorescent-labeled cells, a Zeiss LSM 510meta confocal
microscope (Zeiss, Feldbach, CH) equipped with a Plan-
Neoﬂuar  40/0.50 objective was used. To quantify the
distribution of pyramidal neurons in the developing cortex,
composite images of the prospective somatosensory cortex
were taken at  10 using an epiﬂuorescent microscope (Nikon
Eclipse 90i). TOMþ cells were counted manually using a 10-
bin grid generated in the Metamorph software, and apposed
on the prospective somatosensory cortex of control brains
(n¼9, 2254 cells) and SERT ko brains (n¼9, 2791 cells).
Statistical analysis (GraphPad Prism software, version 4.0)
was done using one-way analysis of variance with Tukey’s
post-hoc tests or using Student’s t-test. Statistical signiﬁcance
was deﬁned at *Po0.05 and **Po0.01, ***Po0.001.
RNA isolation, complementary DNA synthesis and real-
time quantitative PCR. Cortical slices were prepared
and cortices were dissected under a stereo microscope
(Leica M165 FC, Heerbrugg, CH). Total RNA of cortical
tissue from E17.5 and P0.5 was extracted using the RNeasy
Mini kit (Qiagen, Hombrechtikon, CH). The quality of RNA
was checked on an Agilent 2100 Bioanalyser (Agilent
Technologies, Basel, CH) and converted into complementary
DNA using standard procedures (Takara Bio, Shiga, Japan).
SYBR green-based real-time PCR (Qiagen) was used to
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Translational Psychiatryquantify the expression of 5-HT6 receptor (forward primer:
50-GGTGCCATCTGCTTCACCTA-30;r e v e r s ep r i m e r :5 0-CAG
CCAGGTGACAAAGAACA-30). PCRs were performed on an
ABI Prism 7900 Sequence Detection System (Applied Bio-
systems, Carlsbad, CA, USA). Each reaction was performed
in three replicates, and two housekeeping genes were used as
internal controls (beta-actin (actb) and GAPDH).
In situ hybridization. The antisense 5-HT6 receptor
digoxigenin-labeled RNA probe was synthesized by in vitro
transcription using a DIG RNA labeling kit and T7
RNA polymerase (Roche, Rotkreuz, CH). Forward primer:
50-TCCAGGTCTCTTCGATGTCC-30 and reverse primer:
50-CGATGTTAATACGACTCACTATAGGGCCGTATCTCAG
GCTCCACAG-30 (underlined section denotes T7 promoter
and linker sequence) were designed in exon 4 of the 5-HT6
receptor gene. In situ hybridization was performed as
previously described.
28 Brieﬂy, brains of E17.5 and P0.5
mice were dissected and ﬁxed overnight at 41C in 4% PFA.
Coronal sections were cut on a vibratome (50mM thickness)
and mounted on Superfrost Plus slides. Hybridization was
carried out overnight at 601C with the DIG-labeled RNA
probe. Following hybridization, sections were washed and
incubated with alkaline phosphatase-conjugated anti-
digoxigenin antibody (Roche 1:2000) overnight at 41C.
Following incubation, sections were washed and the color
reaction was carried out overnight at 41C in a solution
containing NBT/BCIP (Roche). After color revelation,
sections were washed, post-ﬁxed for 30min in 4% PFA and
mounted with Fluromount (Sigma).
Results
To monitor the migration of excitatory pyramidal neurons
populating superﬁcial cortical layers during the embryonic
period, we performed in utero electroporations of a TOM-
expressing plasmid in the lateral ventricles of E14.5 embryos
andanalyzedthecortexofelectroporatedembryosatdifferent
developmental time points. This method allows efﬁcient
labeling of cortical pyramidal neurons in vivo.
29 After in utero
electroporation at E14.5, a population of TOMþ cells was
located in the E17.5 intermediate zone and displayed the
morphology of pyramidal neurons migrating radially toward
the pial surface (Figure 1a). By E19 a large fraction of TOMþ
cells settled in the cortical plate in prospective layers II/III
(Figure 1b). To directly visualize the migration of pyramidal
neurons, we performed time-lapse imaging for at least 12h
in E17.5 cortical slices after E14.5 in utero electopora-
tions (Figure 1c, Supplementary Movie 1). To more speciﬁ-
cally target late-born layer II pyramidal neurons, in utero
electroporation was performed in the lateral ventricles of
E16.5 embryos. A population of TOMþ pyramidal neurons
with morphologies radially oriented toward the pial surface
Figure 1 Time-lapse imaging of pyramidal neuron migration in cortical slices. (a, b) Confocal images showing that TOMþ pyramidal neurons display radially orientated
migratory-like morphologies in the E17.5 developing cortex (a) and reach their ﬁnal destination in superﬁcial cortical layers at E19 (b). Pyramidal neurons were labeled using
in utero electroporation of a TOMþ-expressing plasmid in the ventricular zone (VZ) at E14.5. (c) Epiﬂuorescent time-lapse images taken from a 12-h time-lapse sequence
showing TOMþ neurons (arrowheads) migrating radially toward the pial surface in a E17.5 cortical slice. Superposed color lines represent migratory tracks. (d) Graph
showing the migratory distances travelled by TOMþ cells shown in panel c2.( e, f) Graphs showing that the mean migratory speed of TOMþ cells does not signiﬁcantly
change during a 12-h time-lapse sequence in E17.5 TOMþ cells labeled at E14.5 (e) and in P0.5 TOMþ cells labeled at E17.5 (f). White boxed area depicts a higher
magniﬁcation image. Scale bars: 50mm.
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tary Movie 2). TOMþ cells located in the intermediate zone
at E17.5 or at P0.5 were tracked during 12h, and no
differences in the mean migratory speed were observed
between TOMþ cells migrating from 0–6h compared with
6–12h (Figures 1c–f; Supplementary Movies 1–2). These
data indicate that in control conditions, TOMþ cells migrate
radially toward the pial surface and that the speed of migra-
tion is stable during the whole duration of the time-lapse
sequence. Finally, to determine whether in utero electropora-
tiontargeting the dorsal pallial VZspeciﬁcally labels excitatory
glutamatergic neurons and not GABAergic interneurons,
in utero electroporation was performed in mice expressing
GFP under the control of the GAD65-GFP promoter
(Figure 2a). GAD65-GFPþ cells were not co-labeled
with TOM, further conﬁrming that in utero electroporation of
the embryonic dorsal pallium speciﬁcally labels excitatory
neuronal precursors.
29
Figure 2 Serotonin decreases the migration speed of pyramidal neurons. (a, b) Confocal images showing that during the process of radial migration, 5-HT positive ﬁbers
(blue) are present in intermediate zone at E17.5 and E19.0, and that GAD65-GFP positive interneurons are not labeled by in utero electroporation. (c1) Epiﬂuorescent time-
lapse images taken from a 12-h time-lapse sequence showing that application of serotonin (400mM) slows the migration of TOMþ neurons (arrowheads) in a P0.5 cortical
slice, and that this effect is reversible after washing serotonin from the medium. Superposed color lines represent migratory tracks. (d) Graph showing the migratory distance
traveledbyTOMþ cellsindicatedinpanelc2.Notethatcellshalttheirmigrationduring5-HTapplicationandgraduallyresumemigrationafterthewash.(e,f)Graphsshowing
that the mean migratory speed of E17.5 TOMþ cells (e) and P0.5 TOMþ cells (f) signiﬁcantly decreases after 5-HT application and is partially restored after 5-HT wash.
White boxed area depicts a higher magniﬁcation image. **Po0.05, GFP, GAD65-GFP. Scale bars: 100mm for a and b,5 0mm for c.
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migration. Immunohistochemistry for serotonin (5-HT) at
E17.5 and E19.0 indicates that TOMþ pyramidal neurons
migrate in the vicinity of 5-HT positive ﬁbers located in
the intermediate zone of the dorsal pallium (Figures 2a, b).
To determine whether 5-HT regulates the migration of
pyramidal neurons, TOMþ neurons migrating radially in
the intermediate zone were ﬁrst monitored during a control
time period of 260min. Serotonin (400mM) was then applied
during 90min in the bath medium. Single-cell tracking
revealed that 5-HT signiﬁcantly reduces the speed of
TOMþ neuron radial migration during its application
(Figures 2c–e). This effect was observed in E17.5 TOMþ
cells electroporated at E14.5 and in P0.5 TOMþ cells
electroporated at E16.5 (Figures 2c–e, Supplementary
Movies 3, 4) indicating that 5-HT regulates the migration of
neocortical pyramidal neurons populating superﬁcial cortical
layers. The effect of 5-HT on pyramidal neuron migration was
reversible. After washing 5-HT from the bath medium,
TOMþ cells were monitored during 590min. During this
time period, E17.5 and P0.5 TOMþ cells gradually resumed
radial migration, indicating that excess of 5-HT does not
irreversibly affect pyramidal neuron migration.
The 5-HT6 receptor is expressed in pyramidal neurons
during cortical development. Previous work from our lab
has demonstrated that activation of the 5-HT6 receptor
inhibits embryonic cortical interneuron migration.
6 In situ
hybridization revealed that the 5-HT6 receptor is expressed
throughout the developing cortex at E17.5 with a stronger
expression in the VZ and cortical plate (Figures 3a, b). In situ
hybridization indicated that 5-HT6 receptor expression
persists in the developing cortex at birth, with a stronger
signal in superﬁcial cortical layers (Figure 3c). Quantitative
PCR performed on mRNA extracted from E17.5 and P0.5
cortices conﬁrmed that the 5-HT6 receptor is expressed in
the developing cortex (Figure 3d). To determine whether
TOMþ pyramidal neurons expressed the 5-HT6 receptor,
E17.5 TOMþ cells electroporated at E14.5 were dissected
from E17.5 cortical slices, isolated using FACS and plated for
cell culture. Immunohistochemistry for the 5-HT6 receptor
was performed using an antibody that speciﬁcally recognizes
the 5-HT6 receptor in 293 T cells over-expressing 5-HT6-
EGFP (Figure 3e). Using this antibody, we observed that
E17.5 TOMþ cells at day in vitro 1 display 5-HT6 receptor
immunoreactivity (Figure 3f) as well as FACS-isolated
GAD65-GFPþ cells (Figure 3g). Immunohistochemistry for
the 5-HT6 receptor on coronal sections at E17.5 revealed
strong 5-HT6 receptor immunoreactivity in the VZ/SVZ as
well as in the cortical plate (Figures 3h, i). Immunostaining for
the 5-HT6 receptor persisted at P0.5 across the developing
cortex with a more pronounced expression in superﬁcial
cortical layers (Figure 3j). Taken together, these data
indicate that migrating pyramidal neurons are likely to
directly respond to 5-HT6 receptor activation.
Activation of the 5-HT6 receptor decreases pyramidal
neuron migration. To determine whether 5-HT6 receptor
activation affects pyramidal neuron migration, migrating
E17.5 TOMþ cells electroporated at E14.5 were exposed
to EMD 386088 (300mM), a speciﬁc agonist of the 5-HT6
receptor. Single-cell tracking revealed that EMD application
signiﬁcantly reduces the speed of TOMþ radial migration
(Figure 4; Supplementary Movie 5). A similar effect of EMD
on pyramidal neuron migration was observed in P0.5 TOMþ
cells electroporated at E16.5 indicating that 5-HT6 receptor
activation slows the migration of pyramidal neurons
populating superﬁcial layers of the neocortex (Figure 4d;
Supplementary Movie 6). After washing EMD from the bath
medium, TOMþ cells monitored at E17.5 and P0.5 gradually
resumed radial migration, indicating that the effects of 5-HT6
receptor activation on pyramidal migration are reversible
(Figures 4c, d).
Excess of serotonin in vivo affects the positioning of
superﬁcial layer cortical neurons. To study the migration
and subsequent layer-speciﬁc positioning of superﬁcial layer
cortical neurons in vivo, we labeled pyramidal neurons
at E14.5 in control and SERT ko mice, and analyzed
the distribution of TOMþ cells at E19.0 in the prospective
somatosensory cortex. Quantiﬁcation of the laminar distri-
bution of TOM-labeled cells at E19.0 revealed that the
proportion of TOM-labeled cells in bin 2 (corresponding to
prospective layer II/III) was signiﬁcantly decreased in SERT
ko mice (Figures 5a–c). Conversely, a signiﬁcantly higher
percentage of TOM-labeled cells were located in bins 3–4
(corresponding to deeper cortical layers, Figures 5a–c).
These data indicate that the positioning of presumptive
superﬁcial cortical neurons is affected in vivo in a mouse
model with increased extracellular levels of serotonin.
Discussion
Using in utero electroporation to label neocortical pyramidal
neurons in combination with time-lapse imaging, we ﬁnd that
an excess of serotonin signiﬁcantly decreases the speed
of migration of superﬁcial layer cortical pyramidal neurons
in cortical slices. The effect of serotonin on neocortical
pyramidal migration is reversible and replicated by application
of EMD, a speciﬁc 5-HT6 receptor agonist. In situ hybridiza-
tion, quantitative PCR and immunohistochemistry reveal that
the 5-HT6 receptor is expressed during embryonic cortical
development in pyramidal neurons populating superﬁcial
cortical layers. Finally, we ﬁnd that the positioning of super-
ﬁcial layer pyramidal neurons is altered in vivo in SERT
ko mice.
Serotonin is detected in the mouse forebrain as early as
E10.5 and is mainly produced by the placenta.
30 Later during
development, when superﬁcial layer neocortical pyramidal
neurons are migrating radially to reach the cortical plate,
serotonin is mainly produced by raphe ﬁbers.
30 Furthermore,
at this time of development, the intermediate zone of the
cortical anlage receives the innervation of thalamo-cortical
axons that express high levels of SERT allowing them to
actively reuptake serotonin from the extracellular space.
31,32
Importantly, the developmental expression of SERT is also
observed in the common marmoset (Callithrix jacchus)
33 and
in the human cortical anlage as early as gestational week
10.
34 It is thus likely that developmental SERT blockade could
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the process of pyramidal neuron migration.
Excess of serotonin is likely to impact neocortical pyramidal
neuron migration through the activation of speciﬁc serotonin
receptors. In a previous study, we have reported that
GABAergic interneurons express the 5-HT6 receptor, and
that activation of this receptor mimics the effects of serotonin
application on the regulation of their migration. In this study,
we have investigated in more detail the developmental
expression of the 5-HT6 receptor using in situ hybridization,
quantitative PCR and immunohistochemistry. Our results
indicate that the 5-HT6 receptor is expressed throughout the
late embryonic developing cortex in accordance with the
pattern of expression reported for the GENSAT 5-HT6 BAC
EGFP reporter line (http://gensat.org). Our data also reveal
that neocortical pyramidal neurons express the 5-HT6
Figure3 The5-HT6receptorisexpressedinpyramidalneuronsduringcorticaldevelopment.(a–c)Insituhybridizationshowingstrongexpressionofthe5-HT6receptorat
E17.5(a, b) and P0.5 (c). (d) QuantitativePCR graph showingno signiﬁcant fold change in the cortical expressionof the 5-HT6 receptor. (e) Confocalimage showing that the
5-HT6 receptor antibody used in this study speciﬁcally recognizes 293 T cells transfected with a 5-HT6-EGFP-over-expressing plasmid. (f, g) Confocal images showing that
TOMþ neurons (f) and GAD65-GFPþ cells (g) express the 5-HT6 receptor at day in vitro 1 in cortical cultures. TOMþ cells were electroporated at E14.5 in GAD-65-GFP
mice, and cortical cultures were prepared at E17.5. (h–j) Composite confocal images showing strong 5-HT6 receptor immunoreactivity at E17.5 in the cortical plate (i) and in
the ventricular zone (VZ)/SVZ (h) and in superﬁcial cortical layers at P0.5 (j). Scale bars: 100mm for a–c,1 0mm for e–g,5 0mm for h–j. GFP, GAD65-GFP; Hst, Hoechst;
aTub, acetylated tubulin.
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Translational PsychiatryFigure4 Activationofthe5-HT6receptordecreasespyramidalneuronmigration.(a)Epiﬂuorescenttime-lapseimagestakenfroma12-hourtime-lapsesequenceshowing
that application of EMD (300mM), a speciﬁc 5-HT6 receptor agonist, decreases the migration of TOMþ neurons (arrowheads) in a P0.5 cortical slice and that this effect is
reversible after washing EMD from the medium. Superposed color lines represent migratory tracks. (b) Graph showing the migratory distance traveled by TOMþ cells
indicatedinpanela.NotethatcellshalttheirmigrationduringEMDapplicationandgraduallyresumesmigrationafterthewash.(c,d)Graphsshowingthatthemeanmigratory
speedofE17.5TOMþ cells(c)andP0.5TOMþ cells(d)signiﬁcantlydecreasesafterEMDapplicationandispartiallyrestoredafterEMDwash.Whiteboxedareadepictsa
higher magniﬁcation image. **Po0.01. GFP, GAD65-GFP. Scale bars: 50mm for a.
Figure 5 The distribution of superﬁcial layer cortical neurons is altered in SERT knockout mice. (a, b) Epiﬂuorescent images of a E19.0 coronal section showing that the
distribution of TOM-labeled neurons in the somatosensory cortex is altered in SERT ko mice compared with wild-type mice. Pyramidal neurons were labeled using in utero
electroporationofaTOMþ-expressingplasmidintheventricularzone(VZ)atE14.5.(c)GraphshowingthatthepercentageofTOM-labeledcellsissigniﬁcantlydecreasedin
superﬁcial cortical layers (bin 2) and signiﬁcantly increased in bin 3–4 in SERT ko mice compared with wild-type mice. ***Po0.001. Scale bars: 50mm.
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this receptor to regulate their migration. Using time-lapse
imaging to monitor the migration of neocortical pyramidal
neurons, we ﬁnd that activation by a speciﬁc agonist of
the 5-HT6 receptor replicates the effects of serotonin. The
mechanisms downstream of 5-HT6 receptor activation in
neocortical pyramidal neurons are currently unknown. The
5-HT6 receptor is a G-coupled protein receptor positively
linked to adenylate cyclase. Increased cyclic AMP levels have
been shown to reduce neuronal migration in invertebrates
35
andinthemammaliancerebellum,
36amechanismassociated
with a reduction of intracellular Ca
2þ transients. A similar
mechanism could follow 5-HT6 receptor activation, but other
downstream transduction pathways are reported and involve
Fyn
37 and JAB1.
38 It is thus likely that the effects of 5-HT6
receptor activation on neocortical pyramidal cell migration are
mediated by various complementary transduction pathways
that need to be further investigated.
SERT ko mice display high levels of extracellular seroto-
nin,
39 and show a broad range of behavioral alterations
ranging from anxiety-like and depressive-like behaviors
to autistic-like behaviors.
40,41 Although the general brain
morphology of SERT ko mice appears grossly normal, quanti-
ﬁcation of the thickness of cortical layers revealed signi-
ﬁcant alterations,
42 suggesting early developmental insults in
neocortical circuit formation. Some of these changes could
be due to alterations in interneuron positioning as described
in superﬁcial cortical layers of the SERT ko mice
6 but also due
to alterations in the positioning of superﬁcial layer neocortical
neurons as found in this study. The alterations in neocortical
pyramidalmigrationdescribedinthisworkaddstothegrowing
body of data demonstrating that excessive levels of serotonin
during critical developmental periods alters basic cellular
processes involved in the formation of neocortical circuits.
How these early-life developmental alterations are causally
related to the broad range of psychiatric-relevant phenotypes
detected in adulthood remains to be investigated. It is likely
that early alterations in neuronal migration and thalamo-
cortical axon wiring may be more related to autistic-like
featuresasobservedinconstitutiveSERTkomice,
41whereas
alterations in amygdalo-prefrontal limbic circuitry may occur
at later developmental steps and be more related to stress-
related phenotypes.
43 Results obtained in SERT deﬁcient
rodent models are relevant for the understanding of human
psychiatric disorders. In humans, the hypofunctional s-allele
moderates a wide range of behavioral dimensions ranging
from autism, depression, neurotic personality traits and
differences in emotional and cognitive processing.
19,21,23,44,45
Several arguments suggest that the behavioral conse-
quences associated to SERT hypofunction/blockade in
humansmayhaveadevelopmentalorigin.First,manystudies
in human
17,19,21,23,46,47 and nonhuman primates
18,20,22,48,49
reveal that the s-allele interacts with developmental adversity
that occurs either during pregnancy or the early postnatal
period. Second, structural brain imaging studies in humans
and nonhuman primates carrying the s-allele reveal gray
matter volume differences in medial limbic regions, which are
suggestive of a developmental origin.
50,51 Finally, selective
serotonin reuptake inhibitors exposure during pregnancy
affects neurobehavioral development
52 and increases the
risk to autism spectrum disorders.
26 Taken together, rodent,
human and non-human primate data strongly suggest that the
developmental set point for 5-HT homeostasis impacts neural
circuit formation and can lead to increased risk for psychiatric-
relevant phenotypes in adulthood. Further studies are needed
to more precisely map the developmental timing of SERT
deﬁciency with altered circuit formation and behavioral
outcomes.
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